Liraglutide relieves cardiac dilated function than DPP-4 inhibitors

about

Liraglutide relieves cardiac dilated function than DPP-4 inhibitors

Item

http://www.wikidata.org/entity/Q58772377

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 16 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

Liraglutide relieves cardiac dilated function than DPP-4 inhibitors

@en

Liraglutide relieves cardiac dilated function than DPP-4 inhibitors

@nl

type

Item

label

Liraglutide relieves cardiac dilated function than DPP-4 inhibitors

@en

Liraglutide relieves cardiac dilated function than DPP-4 inhibitors

@nl

prefLabel

Liraglutide relieves cardiac dilated function than DPP-4 inhibitors

@en

Liraglutide relieves cardiac dilated function than DPP-4 inhibitors

@nl

P1476

Liraglutide relieves cardiac dilated function than DPP-4 inhibitors

@en

P2093

Daiki Iguchi

http://www.w3.org/2001/XMLSchema#string

Kentaro Imai

http://www.w3.org/2001/XMLSchema#string

Masatsuna Mabuchi

http://www.w3.org/2001/XMLSchema#string

Shinji Furuta

http://www.w3.org/2001/XMLSchema#string

Yuko Asano

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of renal impairment on the pharmacokinetics of the GLP-1 analogue liraglutide.

Effect of sitagliptin on the echocardiographic parameters of left ventricular diastolic function in patients with type 2 diabetes: a subgroup analysis of the PROLOGUE study.

A catalogue of reporting guidelines for health research.

Insulin resistance and glycemic abnormalities are associated with deterioration of left ventricular diastolic function: a cross-sectional study.

Left ventricular diastolic function in patients with type 2 diabetes treated with a dipeptidyl peptidase-4 inhibitor- a pilot study.

Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

Liraglutide reduces oxidative stress and restores heme oxygenase-1 and ghrelin levels in patients with type 2 diabetes: a prospective pilot study.

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

The efficacy of incretin therapy in patients with type 2 diabetes undergoing hemodialysis.

Changes in diastolic dysfunction in diabetes mellitus over time.

P304

e13007

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/ECI.13007

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Takeyuki Hiramatsu

P577

2018-08-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30054920

http://www.w3.org/2001/XMLSchema#string

P932

6175244

http://www.w3.org/2001/XMLSchema#string